6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 C화학적 특성, 용도, 생산
용도
6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
6-Desacetyl-6-bromo-N-Boc Palbociclib-d4 준비 용품 및 원자재
